Angiogenetiske faktorer kan bruges ved mistanke om svangerskabsforgiftning

Mille Kyhn Andrea, Jacob Alexander Lykke

Abstract

Pre-eclampsia complicates 7% of pregnancies. The heterogeneity of the syndrome makes it difficult to assess its development and complications, and the current models have low predictive values. Studies indicate a significant difference in the levels of the angiogenic factors: placental growth factor (PlGF) and soluble fms-like tyrosin kinase 1 (sFlt-1), as well as the sFlt-1/PlGF ratio in women with pre-eclampsia compared to women without pre-eclampsia. These angiogenic factors can also be used to help find the women at risk for complications. However, before implementing PlGF and sFlt-1/PlGF ratio in the diagnosis and risk assessment, establishment and further validation of cut-offs are needed.

Bidragets oversatte titelAngiogenic factors can be used when pre-eclampsia is suspected
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind177
Udgave nummer22
Sider (fra-til)V11140638
ISSN0041-5782
StatusUdgivet - 25 maj 2015

Fingeraftryk

Dyk ned i forskningsemnerne om 'Angiogenetiske faktorer kan bruges ved mistanke om svangerskabsforgiftning'. Sammen danner de et unikt fingeraftryk.

Citationsformater